Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue January 22, 2025
Inside information, profit warning: Outokumpu’s fourth-quarter 2024 adjusted EBITDA expected to be close to break-even or turn negative December 12, 2024
